Retatrutide — Research Use Only
Retatrutide is a synthetic peptide investigated in pre-clinical and clinical research for its triple-agonist activity at the GLP-1, GIP, and glucagon receptors. This multi-pathway mechanism makes it a compound of interest in metabolic, energy-balance, and weight-regulation research models.
Overview
Retatrutide is designed to simultaneously influence:
-
GLP-1 receptors – associated with appetite regulation and glucose-dependent insulin secretion
-
GIP receptors – involved in metabolic efficiency and insulin signaling
-
Glucagon receptors – linked to energy expenditure and lipid metabolism
The combined activation profile distinguishes retatrutide from single- or dual-agonist peptides and is the primary reason for its growing research interest.
Research Focus Areas
Current and emerging research is exploring retatrutide in models related to:
-
Metabolic regulation
-
Body-weight and fat-mass reduction pathways
-
Energy expenditure and substrate utilization
-
Glucose and insulin dynamics
Product Characteristics
-
Lyophilized peptide
-
Intended for laboratory and research applications
-
Supplied for controlled, non-human experimental use
Important Notice
This product is for research purposes only.
